A role of Staphyococcus aureus, interleukin-18, nerve growth factor and semaphorin 3A, an axon guidance molecule, in pathogenesis and treatment of atopic dermatitis

Allergy, Asthma and Immunology Research

Volumn 2, Issue 4, 2010, Pages 235-246

  Ikezawa, Zenro ^a   Komori, Junko ^a   Ikezawa, Yuko ^a   Inoue, Yusuke ^a   Kirino, Mio ^a   Katsuyama, Masako ^b   Aihara, Michiko ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHISEIDO RESEARCH CENTER   (Japan)

Author keywords

Atopic dermatitis; Nerve growth factor; Semaphorin 3A; Staphylococcus aureus

Indexed keywords

CONCANAVALIN A; CYCLOPHOSPHAMIDE; FARNESOL; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 18; LACTATE DEHYDROGENASE; NERVE GROWTH FACTOR; OLOPATADINE; SEMAPHORIN 3A; STAPHYLOCOCCUS ENTEROTOXIN B; STEROID; XYLITOL;

ADRENERGIC NERVE; ATOPIC DERMATITIS; BACTERIAL COUNT; BACTERIUM COLONY; BIOFILM; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CREAM; CYTOKINE RELEASE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; EOSINOPHIL COUNT; ERYTHEMA; HUMAN; HYPERSENSITIVITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; INFLAMMATORY INFILTRATE; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPH NODE CELL; NERVE CELL INHIBITION; NONHUMAN; OINTMENT; PATHOGENESIS; PRURITUS; RASH; REGULATORY T LYMPHOCYTE; REVIEW; SKIN DEFECT; SKIN SURFACE; SKINFOLD THICKNESS; STAPHYLOCOCCUS AUREUS; TH1 CELL; XEROSIS;

EID: 77957654538     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2010.2.4.235     Document Type: Review

References (58)

1. Kanbara T, Nakamura K, Tanaka Y, Inoue Y, Tanaka K, Ikezawa Z. A study about the prevalence of infantile atopic dermatitis (the 5th report). Proceedings in Arerugi 2009;58:376.
2. Katsuyama M, Wachi Y, Kitamura K, Suga C, Onuma S, Ikezawa Z. Correlation between the population of staphylococcus aureus on the skin and severity of score of dry type atopic dermatitis condition. Nippon Hifuka Gakkai Zasshi 1997;107:1103-11.
3. Katsuyama M, Ichikawa H, Ogawa S, Ikezawa Z. A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics. J Dermatol Sci 2005;38:197-205.
4. Katsuyama M, Kobayashi Y, Ichikawa H, Mizuno A, Miyachi Y, Matsunaga K, Kawashima M. A novel method to control the balance of skin microflora Part 2. A study to assess the effect of a cream containing farnesol and xylitol on atopic dry skin. J Dermatol Sci 2005;38:207-13.
5. Fujita H, Takahashi H, Aihara M, Hirasawa T, Ikezawa Z. Effects of bamboo leaf extract on atopic dermatitis model mice. J Environ Dermatol 2006;13:87-94.
6. Terada M, Tsutsui H, Imai Y, Yasuda K, Mizutani H, Yamanishi K, Kubo M, Matsui K, Sano H, Nakanishi K. Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice. Proc Natl Acad Sci U S A 2006;103:8816-21. (Pubitemid 43878102)
7. Kirino M, Kirino Y, Takeno M, Nagashima Y, Takahashi K, Kobayashi M, Murakami S, Hirasawa T, Ueda A, Aihara M, Ikezawa Z, Ishigatsubo Y. Heme oxygenase 1 attenuates the development of atopic dermatitis-like lesions in mice: implications for human disease. J Allergy Clin Immunol 2008;122:290-7, 7 e1-8.
8. Matsukura S, Aihara M, Hirasawa T, Ikezawa Z. Effects of TNCB sensitization in DS-Nh mice, serving as a model of atopic dermatitis, in comparison with NC/Nga mice. Int Arch Allergy Immunol 2005;136:173-80. (Pubitemid 40463243)
9. Yoshioka T, Hikita I, Matsutani T, Yoshida R, Asakawa M, Toyosaki- Maeda T, Hirasawa T, Suzuki R, Arimura A, Horikawa T. DS-Nh as an experimental model of atopic dermatitis induced by Staphylococcus aureus producing staphylococcal enterotoxin C. Immunology 2003;108:562-9. (Pubitemid 36469695)
10. Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci 2009;53:48-54.
11. Inoue Y, Aihara M, Harada I, Komori J, Kirino M, Ikezawa Z. Analysis of the pathogenesis by the quantitative measurement of interleukin-18 in the horny layer and Staphylococcus aureus colonization on the skin surface in patients with atopic dermatitis. Proceedings in Arerugi 2009;58:1262.
12. Ikezawa Y. Exacerbative effect of cyclophosphamide on symptom of atopic dermatitis in DS-Nh mouse. Yokohama Medical Journal 2004;55:437-43. (Pubitemid 40754312)
13. Ikezawa Y, Nakazawa M, Tamura C, Takahashi K, Minami M, Ikezawa Z. Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity. J Dermatol Sci 2005;39:105-12. (Pubitemid 41073976)
14. Tatewaki S, Nakazawa M, Aihara M, Hongo N, Hotta Ch, Ikezawa Y, Takahashi K. Minami M, Ikezawa Z. Effects of cyclophosphamide on 2, 4- dinitrofluorobenzene-specific oral tolerance. J Environ Dermatol Cutan Allergol 2007;1:12-21.
15. Yoshioka T, Hikita I, Asakawa M, Hirasawa T, Deguchi M, Matsutani T, Oku H, Horikawa T, Arimura A. Spontaneous scratching behaviour in DS-Nh mice as a possible model for pruritus in atopic dermatitis. Immunology 2006;118:293-301.
16. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002;147:71-9. (Pubitemid 34779440)
17. Pincelli C, Sevignani C, Manfredini R, Grande A, Fantini F, Bracci-Laudiero L, Aloe L, Ferrari S, Cossarizza A, Giannetti A. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 1994;103:13-8. (Pubitemid 24227562)
18. Botchkarev VA, Yaar M, Peters EM, Raychaudhuri SP, Botchkareva NV, Marconi A, Raychaudhuri SK, Paus R, Pincelli C. Neurotrophins in skin biology and pathology. J Invest Dermatol 2006;126:1719-27.
19. Pincelli C, Marconi A. Autocrine nerve growth factor in human keratinocytes. J Dermatol Sci 2000;22:71-9.
20. Huang CH, Kuo IC, Xu H, Lee YS, Chua KY. Mite allergen induces allergic dermatitis with concomitant neurogenic inflammation in mouse. J Invest Dermatol 2003;121:289-93. (Pubitemid 36969902)
21. Peters EM, Raap U, Welker P, Tanaka A, Matsuda H, Pavlovic-Masnicosa S, Hendrix S, Pincelli C. Neurotrophins act as neuroendocrine regulators of skin homeostasis in health and disease. Horm Metab Res 2007;39:110-24. (Pubitemid 46535569)
22. Masahiko T. Useful therapeutic markers of atopic dermatitis: neurogenic factors. Skin Research 2005;4 (Suppl 5):87-93.
23. Dou YC, Hagstromer L, Emtestam L, Johansson O. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res 2006;298:31-7. (Pubitemid 43725210)
24. Kanda N, Watanabe S. Histamine enhances the production of nerve growth factor in human keratinocytes. J Invest Dermatol 2003;121:570-7. (Pubitemid 37072270)
25. Kojima M, Aihara M, Yamada M, Matsukura S, Hirasawa T, Ikezawa Z. Effects of neuropeptides in the development of the atopic dermatitis of mouse models. Allergol Int 2004;53:169-78. (Pubitemid 38899629)
26. Izu K, Tokura Y. The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis. J Dermatol 2005;32:776-81. (Pubitemid 41703752)
27. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989;337:362-4.
28. Braun A, Appel E, Baruch R, Herz U, Botchkarev V, Paus R, Brodie C, Renz H. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 1998;28:3240-51. (Pubitemid 28470270)
29. Tamura T, Matsubara M, Takada C, Hasegawa K, Suzuki K, Ohmori K, Karasawa A. Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice. Br J Dermatol 2004;151:1133-42. (Pubitemid 40030159)
30. Tamura T, Matsubara M, Hasegawa K, Ohmori K, Karasawa A. Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity. Clin Exp Allergy 2005;35:97-103. (Pubitemid 40188277)
31. Tamura T, Amano T, Ohmori K, Manabe H. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice. Eur J Pharmacol 2005;524:149-54. (Pubitemid 41606828)
32. Kruger RP, Aurandt J, Guan KL. Semaphorins command cells to move. Nat Rev Mol Cell Biol 2005;6:789-800.
33. Neufeld G, Kessler O. The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer 2008;8:632-45.
34. Yamaguchi J, Nakamura F, Aihara M, Yamashita N, Usui H, Hida T, Takei K, Nagashima Y, Ikezawa Z, Goshima Y. Semaphorin3A alleviates skin lesions and scratching behavior in NC/Nga mice, an atopic dermatitis model. J Invest Dermatol 2008;128:2842-9.
35. Tominaga M, Ogawa H, Takamori K. Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis. Br J Dermatol 2008;158:842-4. (Pubitemid 351415719)
36. Biro T, Toth BI, Marincsak R, Dobrosi N, Geczy T, Paus R. TRP channels as novel players in the pathogenesis and therapy of itch. Biochim Biophys Acta 2007;1772:1004-21. (Pubitemid 47189633)
37. Kitsukawa T, Shimono A, Kawakami A, Kondoh H, Fujisawa H. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 1995;121:4309-18. (Pubitemid 26007578)
38. Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature 1996;383:525-8. (Pubitemid 26346178)
39. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoformspecific receptor for vascular endothelial growth factor. Cell 1998;92:735-45. (Pubitemid 28155313)
40. Kikutani H, Kumanogoh A. Semaphorins in interactions between T cells and antigen-presenting cells. Nat Rev Immunol 2003;3:159-67.
41. Lepelletier Y, Smaniotto S, Hadj-Slimane R, Villa-Verde DM, Nogueira AC, Dardenne M, Hermine O, Savino W. Control of human thymocyte migration by Neuropilin-1/Semaphorin-3A-mediated interactions. Proc Natl Acad Sci U S A 2007;104:5545-50. (Pubitemid 47175717)
42. Delaire S, Billard C, Tordjman R, Chedotal A, Elhabazi A, Bensussan A, Boumsell L. Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol 2001;166:4348-54. (Pubitemid 32233716)
43. Mangasser-Stephan K, Dooley S, Welter C, Mutschler W, Hanselmann RG. Identification of human semaphorin E gene expression in rheumatoid synovial cells by mRNA differential display. Biochem Biophys Res Commun 1997;234:153-6. (Pubitemid 27267551)
44. Kumanogoh A, Marukawa S, Suzuki K, Takegahara N, Watanabe C, Ch'ng E, Ishida I, Fujimura H, Sakoda S, Yoshida K, Kikutani H. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 2002;419:629-33.
45. Bougeret C, Mansur IG, Dastot H, Schmid M, Mahouy G, Bensussan A, Boumsell L. Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol 1992;148:318-23.
46. Herold C, Bismuth G, Bensussan A, Boumsell L. Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAb. Int Immunol 1995;7:1-8.
47. Hall KT, Boumsell L, Schultze JL, Boussiotis VA, Dorfman DM, Cardoso AA, Bensussan A, Nadler LM, Freeman GJ. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci U S A 1996;93:11780-5. (Pubitemid 26347200)
48. Wu Y, Nadler MJ, Brennan LA, Gish GD, Timms JF, Fusaki N, Jongstra-Bilen J, Tada N, Pawson T, Wither J, Neel BG, Hozumi N. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1. Curr Biol 1998;8:1009-17.
49. Kumanogoh A, Watanabe C, Lee I, Wang X, Shi W, Araki H, Hirata H, Iwahori K, Uchida J, Yasui T, Matsumoto M, Yoshida K, Yakura H, Pan C, Parnes JR, Kikutani H. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 2000;13:621-31.
50. Watanabe C, Kumanogoh A, Shi W, Suzuki K, Yamada S, Okabe M, Yoshida K, Kikutani H. Enhanced immune responses in transgenic mice expressing a truncated form of the lymphocyte semaphorin CD100. J Immunol 2001;167:4321-8. (Pubitemid 32954307)
51. Holmes S, Downs AM, Fosberry A, Hayes PD, Michalovich D, Murdoch P, Moores K, Fox J, Deen K, Pettman G, Wattam T, Lewis C. Sema7A is a potent monocyte stimulator. Scand J Immunol 2002;56:270-5.
52. Kurschat P, Bielenberg D, Rossignol-Tallandier M, Stahl A, Klagsbrun M. Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration. J Biol Chem 2006;281:2721-9. (Pubitemid 43845735)
53. Tordjman R, Lepelletier Y, Lemarchandel V, Cambot M, Gaulard P, Hermine O, Romeo PH. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat Immunol 2002;3:477-82. (Pubitemid 34520798)
54. Lepelletier Y, Moura IC, Hadj-Slimane R, Renand A, Fiorentino S, Baude C, Shirvan A, Barzilai A, Hermine O. Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur J Immunol 2006;36:1782-93. (Pubitemid 44089045)
55. Takano N, Arai I, Kurachi M. Analysis of the spontaneous scratching behavior by NC/Nga mice: a possible approach to evaluate antipruritics for subjects with atopic dermatitis. Eur J Pharmacol 2003;471:223-8. (Pubitemid 36776418)
56. Takano N, Sakurai T, Kurachi M. Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an atopic dermatitis model. J Pharmacol Sci 2005;99:277-86. (Pubitemid 41686452)
57. Pond A, Roche FK, Letourneau PC. Temporal regulation of neuropilin-1 expression and sensitivity to semaphorin 3A in NGF- and NT3-responsive chick sensory neurons. J Neurobiol 2002;51:43-53. (Pubitemid 34242504)
58. Messersmith EK, Leonardo ED, Shatz CJ, Tessier-Lavigne M, Goodman CS, Kolodkin AL. Semaphorin III can function as a selective chemorepellent to pattern sensory projections in the spinal cord. Neuron 1995;14:949-59.